{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:48:22Z","timestamp":1792792102217,"version":"4.5.0"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Hepatitis B virus (HBV) infection persists as a formidable global health predicament, imposing a substantial burden on public health. It not only elevates the risk of cirrhosis but also significantly heightens the incidence of hepatocellular carcinoma (HCC), thereby exacerbating the complexity of managing this disease. Central to the intractability of chronic hepatitis B is the tenacious persistence of covalently closed circular DNA (cccDNA) within the nuclei of infected hepatocytes. This cccDNA serves as a stable transcriptional template, continuously fueling the production of viral components and rendering the virus refractory to current antiviral interventions.\u200b The attainment of a definitive cure for HBV infection hinges upon the development of innovative antiviral strategies that can precisely and effectively target and eliminate cccDNA from the infected liver cells. In this regard, natural products have emerged as a promising source of potential therapeutics. This comprehensive review delves into the natural products that have shown promise in specifically targeting cccDNA. It meticulously elucidates the intricate molecular mechanisms through which these natural compounds modulate cccDNA activity, such as interfering with cccDNA formation, disrupting its epigenetic regulation, or inhibiting its transcriptional output. Developing innovative strategies to target and eliminate cccDNA is crucial for curing HBV infection, and natural products hold great promise. This review details several natural products with cccDNA-targeting potential, supported by clear mechanisms and data. Dehydrocheilanthifolin (DHCH) from <jats:italic>Corydalis saxicola<\/jats:italic> inhibits HBsAg and HBeAg secretion in HepG2.2.15 cells. It may disrupt viral processes like pgRNA packaging or DNA polymerase activity, with IC50 values for reducing extracellular, intracellular DNA, and cccDNA at 15.08 \u03bcM, 7.62 \u03bcM, and 8.25 \u03bcM respectively. Methyl helicterate from <jats:italic>Helicteres angustifolia<\/jats:italic> decreases HBsAg, HBeAg, HBV DNA, and cccDNA in HepG2.2.15 cells. 15.8 \u03bcM reduces intracellular cccDNA. Curcumin from turmeric reduces viral load and cccDNA in d-imHCs; 30\u00b5M halves cccDNA levels. Epigallocatechin gallate (EGCG) from green tea hinders viral transcription and replication. 22.9\u03bcg\/ml EGCG lowers cccDNA by about 60%. Asiaticoside from <jats:italic>Hydrocotyle sibthorpioides<\/jats:italic> inhibits HBsAg, HBeAg, and cccDNA in HepG2.2.15 cells. Notably, despite extensive research, no natural product has yet obtained clinical validation for cccDNA clearance, highlighting the significant translational gap between pre-clinical research and clinical application. By elucidating these molecular mechanisms, this review aims to contribute to the development of HBV-targeted therapies, offering valuable insights for designing novel therapeutic agents and optimizing existing treatment regimens, ultimately advancing the quest for an effective cure for HBV infection.<\/jats:p>","DOI":"10.3389\/fcimb.2025.1598872","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:29:13Z","timestamp":1750138153000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Therapeutic interventions aimed at cccDNA: unveiling mechanisms and evaluating the potency of natural products"],"prefix":"10.3389","volume":"15","author":[{"given":"Liyuan","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"B2","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/s2468-1253(23)00197-8","article-title":"Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: A modelling study","volume":"8","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear hbx binds the hbv minichromosome and modifies the epigenetic regulation of cccdna function","volume":"106","author":"Belloni","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1128\/JVI.02574-12","article-title":"Methyltransferase prmt1 is a binding partner of hbx and a negative regulator of hepatitis B virus transcription","volume":"87","author":"Benhenda","year":"2013","journal-title":"J. Virol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1177\/10781552241251757","article-title":"Advancements in the use of nanopharmaceuticals for cancer treatment","volume":"30","author":"Bennani","year":"2024","journal-title":"J. Oncol. Pharm. Pract."},{"key":"B6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.virol.2018.03.011","article-title":"Impact of immune escape mutations and N-linked glycosylation on the secretion of hepatitis B virus virions and subviral particles: role of the small envelope protein","volume":"518","author":"Bi","year":"2018","journal-title":"Virology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4254\/wjh.v10.i3.352","article-title":"Reactivation of hepatitis B after liver transplantation: current knowledge, molecular mechanisms and implications in management","volume":"10","author":"Chauhan","year":"2018","journal-title":"World J. Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jhep.2020.09.019","article-title":"Dicoumarol, an nqo1 inhibitor, blocks cccdna transcription by promoting degradation of hbx","volume":"74","author":"Cheng","year":"2021","journal-title":"J. Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3390\/molecules27010139","article-title":"A narrative review on the phytochemistry, pharmacology and therapeutic potentials of clinacanthus nutans (Burm. F.) lindau leaves as an alternative source of future medicine","volume":"27","author":"Chia","year":"2021","journal-title":"Molecules"},{"key":"B10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3892\/br.2016.601","article-title":"Cimicifuga foetida L. Plus adefovir effectively inhibits the replication of hepatitis B virus in patients with chronic hepatitis B","volume":"4","author":"Dai","year":"2016","journal-title":"BioMed. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the smc5\/6 complex as a host restriction factor","volume":"531","author":"Decorsi\u00e8re","year":"2016","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/molecules29030689","article-title":"Medicinal chemistry strategies for the modification of bioactive natural products","volume":"29","author":"Ding","year":"2024","journal-title":"Molecules (Basel Switzerland)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.antiviral.2022.105482","article-title":"Ciliatoside a, isolated from peristrophe japonica, inhibits hbsag expression and cccdna transcription by inducing autophagy","volume":"209","author":"Fang","year":"2023","journal-title":"Antiviral Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B15","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/mnfr.201000641","article-title":"The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention","volume":"55","author":"Forester","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jep.2012.06.031","article-title":"Pharmacokinetics and bioavailability of cimicifugosides after oral administration of cimicifuga foetida L. Extract to rats","volume":"143","author":"Gai","year":"2012","journal-title":"J. Ethnopharmacol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/hep.29316","article-title":"Hepatitis B virus X protein-elevated msl2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of apobec3b to enhance hepatocarcinogenesis","volume":"66","author":"Gao","year":"2017","journal-title":"Hepatol. (Baltimore Md)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3892\/mmr.2024.13224","article-title":"Dicoumarol attenuates nlrp3 inflammasome activation to inhibit inflammation and fibrosis in knee osteoarthritis","volume":"29","author":"Ge","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"720","DOI":"10.4161\/epi.6.6.15815","article-title":"Hbc binds to the cpg islands of hbv cccdna and promotes an epigenetic permissive state","volume":"6","author":"Guo","year":"2011","journal-title":"Epigenetics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jep.2023.117162","article-title":"Corydalis saxicola bunting total alkaloids improve nafld by suppressing de novo lipogenesis through the ampk-srebp1 axis","volume":"319","author":"Guo","year":"2024","journal-title":"J. Ethnopharmacol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jep.2012.09.003","article-title":"Hepatoprotective and antiviral properties of isochlorogenic acid a from laggera alata against hepatitis B virus infection","volume":"144","author":"Hao","year":"2012","journal-title":"J. Ethnopharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1099\/0022-1317-80-3-607","article-title":"A cellular protein which binds hepatitis B virus but not hepatitis B surface antigen","volume":"80","author":"Harvey","year":"1999","journal-title":"J. Gen. Virol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"9471","DOI":"10.1128\/JVI.74.20.9471-9478.2000","article-title":"The binding site of transcription factor yy1 is required for intramolecular recombination between terminally repeated sequences of linear replicative hepatitis B virus DNA","volume":"74","author":"Hayashi","year":"2000","journal-title":"J. Virol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1016\/j.fct.2011.07.007","article-title":"A subacute toxicity evaluation of green tea (Camellia sinensis) extract in mice","volume":"49","author":"Hsu","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.antiviral.2013.09.007","article-title":"Antiviral activity of methyl helicterate isolated from helicteres angustifolia (Sterculiaceae) against hepatitis B virus","volume":"100","author":"Huang","year":"2013","journal-title":"Antiviral Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jep.2012.08.018","article-title":"Effect and mechanism of methyl helicterate isolated from helicteres angustifolia (Sterculiaceae) on hepatic fibrosis induced by carbon tetrachloride in rats","volume":"143","author":"Huang","year":"2012","journal-title":"J. Ethnopharmacol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.jep.2013.09.009","article-title":"Isolation and identification of an anti-hepatitis B virus compound from hydrocotyle sibthorpioides lam","volume":"150","author":"Huang","year":"2013","journal-title":"J. Ethnopharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1039\/d0np00034e","article-title":"Chemical labeling strategies for small molecule natural product detection and isolation","volume":"38","author":"Hughes","year":"2021","journal-title":"Natural product Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"018","DOI":"10.1038\/s41598-018-26114-z","article-title":"Malonylation of histone H2a at lysine 119 inhibits bub1-dependent H2a phosphorylation and chromosomal localization of shugoshin proteins","volume":"8","author":"Ishiguro","year":"2018","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"8487","DOI":"10.1073\/pnas.1811064116","article-title":"Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization","volume":"116","author":"Iwamoto","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B31","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/cr.2017.16","article-title":"A non-viral crispr\/cas9 delivery system for therapeutically targeting hbv DNA and pcsk9 in vivo","volume":"27","author":"Jiang","year":"2017","journal-title":"Cell Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1586\/17474124.2.4.553","article-title":"Diagnosis of hepatitis B virus infection through serological and virological markers","volume":"2","author":"Kao","year":"2008","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/nsmb.3490","article-title":"Histone propionylation is a mark of active chromatin","volume":"24","author":"Kebede","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.36519\/idcm.","article-title":"New treatment options in chronic hepatitis B: how close are we to cure","volume":"5","author":"Korkmaz","year":"2023","journal-title":"Infect. Dis. Clin. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3748\/wjg.v17.i3.283","article-title":"Quantification of hbsag: basic virology for clinical practice","volume":"17","author":"Lee","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/cbdv.200890074","article-title":"Alkaloids from corydalis saxicola and their anti-hepatitis B virus activity","volume":"5","author":"Li","year":"2008","journal-title":"Chem. Biodivers"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00582","article-title":"Isochlorogenic acid a attenuates the progression of liver fibrosis through regulating hmgb1\/tlr4\/nf-\u039ab signaling pathway","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","article-title":"Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection","volume":"55","author":"Lucifora","year":"2011","journal-title":"J. Hepatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1111\/febs.13110","article-title":"Genome modification by crispr\/cas9","volume":"281","author":"Ma","year":"2014","journal-title":"FEBS J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jhep.2021.05.013","article-title":"Covalently closed circular DNA: the ultimate therapeutic target for curing hbv infections","volume":"75","author":"Martinez","year":"2021","journal-title":"J. Hepatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.3390\/v14122654","article-title":"Gene editing technologies to target hbv cccdna","volume":"14","author":"Martinez","year":"2022","journal-title":"Viruses"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1053\/jhep.2003.50453","article-title":"Exploring the biological basis of hepatitis B E antigen in hepatitis B virus infection","volume":"38","author":"Milich","year":"2003","journal-title":"Hepatol. (Baltimore Md)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"834","DOI":"10.3390\/cells9040834","article-title":"Hepatitis B virus hbx protein mediates the degradation of host restriction factors through the cullin 4 ddb1 E3 ubiquitin ligase complex","volume":"9","author":"Minor","year":"2020","journal-title":"Cells"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.drudis.2017.07.001","article-title":"Curcumin and its topical formulations for wound healing applications","volume":"22","author":"Mohanty","year":"2017","journal-title":"Drug Discov. Today"},{"key":"B45","doi-asserted-by":"publisher","first-page":"7780","DOI":"10.1039\/c5ob00449g","article-title":"Hepatitis B virus peptide inhibitors: solution structures and interactions with the viral capsid","volume":"13","author":"Muhamad","year":"2015","journal-title":"Organic biomolecular Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"7651","DOI":"10.3390\/ijms24087651","article-title":"Hbv infection and host interactions: the role in viral persistence and oncogenesis","volume":"24","author":"Nevola","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1128807","article-title":"The progress of molecules and strategies for the treatment of hbv infection","volume":"13","author":"Pan","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/srep30374","article-title":"Stronger enhancer ii\/core promoter activities of hepatitis B virus isolates of B2 subgenotype than those of C2 subgenotype","volume":"6","author":"Qin","year":"2016","journal-title":"Sci. Rep."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1002\/hep.29912","article-title":"Sirt3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3\u20139 homolog 1 and set domain containing 1a histone methyltransferases","volume":"68","author":"Ren","year":"2018","journal-title":"Hepatology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28578","article-title":"Sphondin efficiently blocks hbsag production and cccdna transcription through promoting hbx degradation","volume":"95","author":"Ren","year":"2023","journal-title":"J. Med. Virol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","article-title":"Hbx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccdna involving setdb1 histone methyltransferase","volume":"63","author":"Rivi\u00e8re","year":"2015","journal-title":"J. Hepatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"01840","DOI":"10.1128\/JVI.01840-18","article-title":"Parvulin 14 and parvulin 17 bind to hbx and cccdna and upregulate hepatitis B virus replication from cccdna to virion in an hbx-dependent manner","volume":"93","author":"Saeed","year":"2019","journal-title":"J. Virol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1427519","article-title":"Peripheral nk cell phenotypic alteration and dysfunctional state post hepatitis B subviral particles stimulation in chb patients: evading immune surveillance","volume":"15","author":"Selim","year":"2024","journal-title":"Front. Immunol."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2023.102112","article-title":"Cytosine Base Editing Inhibits Hepatitis B Virus Replication and Reduces Hbsag Expression In vitro and In vivo","volume":"35","author":"Smekalova","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.2174\/1568026621666210915121957","article-title":"Nanocarriers as administration systems of natural products","volume":"21","author":"Sol\u00eds-Cruz","year":"2021","journal-title":"Curr. topics medicinal Chem."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2021.105107","article-title":"E3 ubiquitin ligase trim21 restricts hepatitis B virus replication by targeting hbx for proteasomal degradation","volume":"192","author":"Song","year":"2021","journal-title":"Antiviral Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3390\/ijms25020759","article-title":"Furanocoumarins as enhancers of antitumor potential of sorafenib and ly294002 toward human glioma cells in vitro","volume":"25","author":"Sumorek-Wiadro","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"863","DOI":"10.4254\/wjh.v8.i21.863","article-title":"New horizon for radical cure of chronic hepatitis B virus infection","volume":"8","author":"Tajiri","year":"2016","journal-title":"World J. Hepatol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1006\/jmbi.1998.2525","article-title":"Two distinct segments of the hepatitis B virus surface antigen contribute synergistically to its association with the viral core particles","volume":"286","author":"Tan","year":"1999","journal-title":"J. Mol. Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"12455","DOI":"10.1093\/nar\/gku925","article-title":"Requirement of crtc1 coactivator for hepatitis B virus transcription","volume":"42","author":"Tang","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.intimp.2023.109989","article-title":"Isochlorogenic acid a alleviates dextran sulfate sodium-induced ulcerative colitis in mice through stat3\/nf-\u041ab pathway","volume":"118","author":"Tang","year":"2023","journal-title":"Int. Immunopharmacol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"021","DOI":"10.1038\/s41598-021-98243-x","article-title":"Curcumin inhibited hepatitis B viral entry through ntcp binding","volume":"11","author":"Thongsri","year":"2021","journal-title":"Sci. Rep."},{"key":"B64","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.antiviral.2020.104925","article-title":"Hepatitis B virus biology and life cycle","volume":"182","author":"Tsukuda","year":"2020","journal-title":"Antiviral Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/v12020160","article-title":"Host transcription factors in hepatitis B virus rna synthesis","volume":"12","author":"Turton","year":"2020","journal-title":"Viruses"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2024.110065","article-title":"Furanocoumarins promote proteasomal degradation of viral hbx protein and down-regulate cccdna transcription and replication of hepatitis B virus","volume":"595","author":"Tyagi","year":"2024","journal-title":"Virology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1021\/acsinfecdis.0c00638","article-title":"Hbsag, subviral particles, and their clearance in establishing a functional cure of chronic hepatitis B virus infection","volume":"7","author":"Vaillant","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.724877","article-title":"The hepatitis B virus interactome: A comprehensive overview","volume":"12","author":"Van Damme","year":"2021","journal-title":"Front. Microbiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/hep.28013","article-title":"A targeted functional rna interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses","volume":"63","author":"Verrier","year":"2016","journal-title":"Hepatology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1128\/JVI.02280-09","article-title":"Hepatitis B virus replication induces methylation of both host and viral DNA","volume":"84","author":"Vivekanandan","year":"2010","journal-title":"J. Virol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12951-021-01233-4","article-title":"Crispr\/cas9 delivery by nir-responsive biomimetic nanoparticles for targeted hbv therapy","volume":"20","author":"Wang","year":"2022","journal-title":"J. nanobiotechnology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nature25003","article-title":"Kat2a coupled with the \u0391-kgdh complex acts as a histone H3 succinyltransferase","volume":"552","author":"Wang","year":"2017","journal-title":"Nature"},{"key":"B73","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/metabo13010009","article-title":"Investigation of the therapeutic effect of total alkaloids of corydalis saxicola bunting on ccl(4)-induced liver fibrosis in rats by lc\/ms-based metabolomics analysis and network pharmacology","volume":"13","author":"Wang","year":"2022","journal-title":"Metabolites"},{"key":"B74","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jhep.2022.12.014","article-title":"Discovery of a first-in-class orally available hbv cccdna inhibitor","volume":"78","author":"Wang","year":"2023","journal-title":"J. Hepatol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.3390\/nu11122989","article-title":"Mechanistic understanding of curcumin\u2019s therapeutic effects in lung cancer","volume":"11","author":"Wan Mohd Tajuddin","year":"2019","journal-title":"Nutrients"},{"key":"B76","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/cr.2017.68","article-title":"Class I histone deacetylases are major histone decrotonylases: evidence for critical and broad function of histone crotonylation in transcription","volume":"27","author":"Wei","year":"2017","journal-title":"Cell Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"6252","DOI":"10.3748\/wjg.v23.i34.6252","article-title":"Curcumin inhibits hepatitis B virus infection by down-regulating cccdna-bound histone acetylation","volume":"23","author":"Wei","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jhep.2021.11.024","article-title":"How to achieve functional cure of hbv: stopping nucs, adding interferon or new drug development","volume":"76","author":"Wong","year":"2022","journal-title":"J. Hepatol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.biopha.2022.113132","article-title":"Corydalis saxicola bunting total alkaloids ameliorate diet-induced non-alcoholic steatohepatitis by regulating hepatic pi3k\/akt and tlr4\/nf-\u039ab pathways in mice","volume":"151","author":"Wu","year":"2022","journal-title":"BioMed. Pharmacother."},{"key":"B80","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.antiviral.2007.11.011","article-title":"Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro","volume":"78","author":"Xu","year":"2008","journal-title":"Antiviral Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"00049","DOI":"10.7554\/eLife.00049.027","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"13","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"B82","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.bbrc.2004.05.061","article-title":"A new compound from micromonospora sp. Sa246, 9-hydroxycrisamicin-a, activates hepatitis B virus replication","volume":"319","author":"Yoon","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B83","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.antiviral.2019.104619","article-title":"Hdac11 restricts hbv replication through epigenetic repression of cccdna transcription","volume":"172","author":"Yuan","year":"2019","journal-title":"Antiviral Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1142\/S0192415X13500092","article-title":"Anti-hepatitis B virus effects of dehydrocheilanthifoline from corydalis saxicola","volume":"41","author":"Zeng","year":"2013","journal-title":"Am. J. Chin. Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1159\/000495390","article-title":"Methyl helicterate inhibits hepatic stellate cell activation through modulation of apoptosis and autophagy","volume":"51","author":"Zhang","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"B86","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/hep.29133","article-title":"Prmt5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic rna encapsidation","volume":"66","author":"Zhang","year":"2017","journal-title":"Hepatology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"5625222","DOI":"10.1155\/2023\/5625222","article-title":"Protective effects of clinacanthus nutans (Burm.F.) lindau aqueous extract on hbv mouse model by modulating gut microbiota and liver metabolomics","volume":"3","author":"Zhang","year":"2023","journal-title":"Evid Based Complement Alternat Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"258","DOI":"10.14218\/JCTH.2018.00054","article-title":"Hbv cccdna and its potential as a therapeutic target","volume":"7","author":"Zhu","year":"2019","journal-title":"J. Clin. Transl. Hepatol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1598872\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:29:13Z","timestamp":1750138153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1598872\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":88,"alternative-id":["10.3389\/fcimb.2025.1598872"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1598872","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"article-number":"1598872"}}